UNIVERSITY OF ARIZONA

UNIVERSITY OF ARIZONA logo
🇺🇸United States
Ownership
Private
Established
1885-01-01
Employees
10K
Market Cap
-
Website
http://www.arizona.edu

Acupuncture as Complementary Therapy for Cerebral Palsy

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-09-22
Last Posted Date
2016-05-16
Lead Sponsor
University of Arizona
Target Recruit Count
75
Registration Number
NCT00221247
Locations
🇨🇳

Beijing Children's Hospital, Beijing, Beijing, China

🇺🇸

The University of Arizona, Department of Pediatrics, Tucson, Arizona, United States

Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-08-15
Last Posted Date
2012-05-28
Lead Sponsor
University of Arizona
Target Recruit Count
40
Registration Number
NCT00130520
Locations
🇺🇸

University of Arizona Cancer Center, Tucson, Arizona, United States

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

First Posted Date
2004-12-09
Last Posted Date
2010-03-24
Lead Sponsor
University of Arizona
Target Recruit Count
40
Registration Number
NCT00098800
Locations
🇺🇸

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

First Posted Date
2004-09-09
Last Posted Date
2010-01-20
Lead Sponsor
University of Arizona
Registration Number
NCT00091325
Locations
🇺🇸

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome

Phase 1
Completed
Conditions
First Posted Date
2004-08-03
Last Posted Date
2013-01-31
Lead Sponsor
University of Arizona
Target Recruit Count
26
Registration Number
NCT00003415
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

First Posted Date
2004-08-02
Last Posted Date
2013-01-31
Lead Sponsor
University of Arizona
Target Recruit Count
30
Registration Number
NCT00003068
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

First Posted Date
2004-07-19
Last Posted Date
2010-03-16
Lead Sponsor
University of Arizona
Target Recruit Count
27
Registration Number
NCT00003082
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-04-14
Last Posted Date
2010-03-16
Lead Sponsor
University of Arizona
Target Recruit Count
25
Registration Number
NCT00003307
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Selenium for Prevention of Adenomatous Colorectal Polyps

First Posted Date
2004-03-09
Last Posted Date
2019-09-24
Lead Sponsor
University of Arizona
Target Recruit Count
1621
Registration Number
NCT00078897
Locations
🇺🇸

Endoscopy Center of Western New York, Williamsville, New York, United States

🇺🇸

Baylor University Medical Center - Dallas, Dallas, Texas, United States

🇺🇸

Veterans Affairs Medical Center - Phoenix, Phoenix, Arizona, United States

and more 4 locations

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

First Posted Date
2004-02-16
Last Posted Date
2018-09-11
Lead Sponsor
University of Arizona
Registration Number
NCT00021294
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath